Stansberry Asset Management, LLC Paratek Pharmaceuticals, Inc. Transaction History

Stansberry Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $667,962 - $808,197	-73,808 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $15,616 - $21,280	-1,531 Reduced 2.03%	73,808 $753,000
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $44,743 - $66,672	3,537 Added 4.93%	75,339 $979,000
Q4 2017 Feb 12, 2018	BUY	$17.45 - $25.6 $1.25 Million - $1.84 Million	71,802	71,802 $1.29 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stansberry Asset Management, LLC with notifications on news.